Published in Zentralbl Bakteriol on October 01, 1994
Fermentative and serological studies on Propionibacterium acnes. Appl Microbiol (1973) 1.71
Implant infections: a haven for opportunistic bacteria. J Hosp Infect (2001) 1.49
Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species. Antimicrob Agents Chemother (1976) 1.44
Studies on bacteriophages of Propionibacterium acnes. Med Microbiol Immunol (1975) 1.33
Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res (2004) 1.33
Actinobacillus actinomycetem-comitans: fermentative capabilities of 140 strains. Appl Microbiol (1970) 1.31
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin. Med Microbiol Immunol (1985) 1.19
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
[Occurrence of NAG vibrios (non-cholera vibrios) in West Germany]. Dtsch Med Wochenschr (1973) 1.09
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
[Bacteriophages of Propionibacterium acnes (author's transl)]. Zentralbl Bakteriol Orig A (1973) 1.01
Serological studies on Actinobacillus actinomycetem-comitans. Appl Microbiol (1972) 1.00
Antimicrobial substances and effects on sessile bacteria. Zentralbl Bakteriol (1999) 0.97
Differential susceptibility of Propionibacterium acnes, P. granulosum and P. avidum to free fatty acids. J Invest Dermatol (1978) 0.97
Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study. Anticancer Res (2004) 0.93
[Animal experiment studies on the modification of the immune system by ofloxacin]. Infection (1986) 0.93
Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment. Anticancer Res (1996) 0.92
Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H). Anticancer Res (1999) 0.91
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]. Pneumologie (2011) 0.91
Stimulation of human monocyte chemiluminescence by staphylococcal lipoteichoic acid. Med Microbiol Immunol (1988) 0.90
Qualitative and quantitative investigations on the resident bacterial skin flora in healthy persons and in the non-affected skin of patients with seborrheic Eczema. Arch Dermatol Res (1980) 0.89
Keyhole limpet hemocyanin for carcinoma in situ of the bladder: a long-term follow-up study. Eur Urol (2000) 0.88
[Special aspects of implant-associated infection in orthopedic surgery. From the pathophysiology to custom-tailored prevention strategies]. Orthopade (2004) 0.88
The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J Antimicrob Chemother (2000) 0.87
Immunomodulation by propionibacteria. Zentralbl Bakteriol (1990) 0.87
[Immunomodulating effects of antibiotics influencing digestive flora]. Pathol Biol (Paris) (1993) 0.86
Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma. Anticancer Res (1996) 0.84
The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection. Am J Med (1999) 0.84
Effects of ciprofloxacin on the humoral and cellular immune responses in Balb/c-mice. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.84
Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study. Diabetologia (2003) 0.84
Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res (1994) 0.84
Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; an overview of current literature. Zentralbl Bakteriol (1996) 0.84
Hemagglutination by Staphylococcus saprophyticus and other coagulase-negative staphylococci. Microb Pathog (1988) 0.84
Importance of lectins for the prevention of bacterial infections and cancer metastases. Glycoconj J (1995) 0.84
The correlation of susceptibility of different Propionibacterium strains to macrophage killing and antitumor activity. Med Microbiol Immunol (1980) 0.83
Type of fimbriation determines adherence of Klebsiella bacteria to human epithelial cells. Zentralbl Bakteriol (1990) 0.83
Clotting and fibrinolytic activities of Bacteroides melaninogenicus. Zentralbl Bakteriol Orig A (1977) 0.83
Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1. In Vivo (1994) 0.83
Silver coating of medical devices for catheter-associated infections? Am J Med (1999) 0.83
Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Anticancer Res (1998) 0.82
Biological properties of staphylococcal lipoteichoic acid and related macromolecules. Zentralbl Bakteriol (1990) 0.82
Immunostimulating staphylococcal lipoteichoic acid prevents pulmonary tumor colonization in BALB/c-mice. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 0.82
Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models. Cancer Lett (2001) 0.81
Lectin mediated adhesion of Streptococcus pneumoniae and its specific inhibition in vitro and in vivo. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.81
INfluence of Pseudomonas aeruginosa proteases on prothrombin, plasminogen and fibrinogen. Zentralbl Bakteriol A (1980) 0.81
Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res (2000) 0.81
Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice. Anticancer Res (2002) 0.81
Influence of complementary Viscum album (Iscador) administration on microcirculation and immune system of ear, nose and throat carcinoma patients treated with radiation and chemotherapy. Anticancer Res (2005) 0.81
Silver-containing polymers. Antimicrob Agents Chemother (1999) 0.81
Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose. J Cancer Res Clin Oncol (1987) 0.81
Evaluation of absorbed radiation dose to working staff during cardiac catheterization procedures. Zhonghua Yi Xue Za Zhi (Taipei) (2000) 0.81
Measurement of ultrasonic-induced chlorhexidine liberation: correlation of the activity of chlorhexidine-silver-sulfadiazine-impregnated catheters to agar roll technique and broth culture. J Hosp Infect (2000) 0.80
Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin Investig (1992) 0.80
Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models. Anticancer Res (2003) 0.80
[Differentiation of various Propionibacterium species from acne-vulgaris efflorescences]. Hautarzt (1979) 0.80
Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci. Zentralbl Bakteriol (1998) 0.80
Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice. J Cancer Res Clin Oncol (1988) 0.79
"Difficult to treat infections" pharmacokinetic and pharmacodynamic factors--a review. Acta Microbiol Immunol Hung (2000) 0.79
Novel strategies to prevent catheter-associated infections in oncology patients. J Chemother (2001) 0.79
Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder. Anticancer Res (1996) 0.79
Reduced side-effects of adjuvant hormone therapy in breast cancer patients by complementary medicine. In Vivo (2010) 0.79
Modification of glycosylation by tunicamycin treatment inhibits lectin-mediated adhesion of Streptococcus pneumoniae to various tissues. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.79
Intratumoral application of standardized mistletoe extracts down regulates tumor weight via decreased cell proliferation, increased apoptosis and necrosis in a murine model. Anticancer Res (2007) 0.78
Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan. Clin Exp Metastasis (1988) 0.78
Lectins: mediators of adhesion for bacteria in infectious diseases and for tumor cells in metastasis. Zentralbl Bakteriol (1990) 0.78
Adherent bacteria and activity of antibiotics. J Antimicrob Chemother (1999) 0.78
Digestive tract microflora liberates low molecular weight peptides with immunotriggering activity. Zentralbl Bakteriol (1990) 0.78
Enhancement of circulating dendritic cell activity by immunomodulators (OK432 and KP-40). Anticancer Res (2002) 0.78
Liver lectins: mediators for metastases? Experientia (1983) 0.78
[Effect of mistletoe lectin therapy on serum level of defined serum proteins (acute phase proteins) in tumor patients]. Med Klin (Munich) (1993) 0.78
[Nutritional requirements of Bacteroides melaninogenicus]. Zentralbl Bakteriol Orig A (1974) 0.78
[Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract]. Arzneimittelforschung (1993) 0.77
[Immunoactive effects of various mistletoe lectin-1 dosages in mammary carcinoma patients]. Arzneimittelforschung (1995) 0.77
Activation of mononuclear immune cells in response to staphylococcal lipoteichoic acid. Zentralbl Bakteriol (1991) 0.77
[Immunoactive action of mistletoe lectin-1 in relation to dose]. Arzneimittelforschung (1994) 0.77
Comparative study on the immunostimulatory potency of different Propionibacterium strains. Med Microbiol Immunol (1981) 0.77
Efficiency of treatment with galactoside-specific lectin from mistletoe against rat glioma. Anticancer Res (1998) 0.77
Are ABH antigenic determinants on human outer ear canal epithelium responsible for Pseudomonas aeruginosa infections? ORL J Otorhinolaryngol Relat Spec (1995) 0.77
Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients. Anticancer Res (1997) 0.77
Prevention of experimental liver metastases by arabinogalactan. Naturwissenschaften (1986) 0.77
Influence of 12 antibiotics on antitumor immunity in BALB/c-mice. Zentralbl Bakteriol (1992) 0.77
Respiratory burst of human polymorphonuclear leukocytes in response to the galactoside-specific mistletoe lectin. Zentralbl Bakteriol (1995) 0.77